Kost Capital, founded in Copenhagen and active in Europe with investering in early-stage companies in food, health, and nutrition, has this week announced they appointed Jonas Ahm-Lundgren as General Partner, alongside founder Bodil Sidén.
Jonas brings 15 years of experience from biotech and health investments, most recently as a partner at The Footprint Firm, and before that with investments at Novo Holdings and strategy work at the Novo Nordisk Foundation.
The recruitment comes as Kost Capital builds its second fund, focused on what the company calls human energy: the technologies, ingredients, and brands that determine how people eat, perform, and live. On average, people live almost ten years of their lives in poor health, and the loss of healthy life years due to metabolic risk factors has increased by 49 percent since 2000.
“Jonas has been my favourite among venture capitalists for many years. He knows how science becomes a company. I know how a company becomes a brand that people buy. Together we can back human energy founders all the way from the lab to the shelf,”
said Bodil Sidén, General Partner at Kost Capital.
Since 2023, Kost Capital has made more than 15 investments from its first €18 million fund, including Orbisk, Foreverland, and Aventix, while its studio, Kost Studio, has built close to 10 companies. The fund’s investors include EIFO, Deichmann, Sagitta, and Re:food.
“Food, health, and biology meet in exactly one place: in a body converting a meal. It is the biggest health lever we have, and no fund in Europe is dedicated to it. Bodil has built the network and the credentials to own the category, and I look enormously forward to building it together with her,”
said Jonas Ahm-Lundgren.
Bodil Sidén, who founded Kost Capital after building BLQ Invest I and II and previously helped scale Uber in the Nordics and worked in Swedish politics, is moving to Stockholm, giving the fund partners in both Copenhagen and Stockholm.
